Stroke following percutaneous coronary intervention: Type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12

European Heart Journal

Volumn 36, Issue 25, 2015, Pages 1618-1628

  Kwok, Chun Shing ^a   Kontopantelis, Evangelos ^a   Myint, Phyo K ^b   Zaman, Azfar ^c   Berry, Colin ^d   Keavney, Bernard ^a   Nolan, Jim ^e   Ludman, Peter F ^f   De Belder, Mark A ^g   Buchan, Iain ^a   Mamas, Mamas A ^a,h  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d ROYAL JUBILEE HOSPITAL   (Canada)

^e UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^f QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^g JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^h KEELE UNIVERSITY   (United Kingdom)

Author keywords

Outcomes; PCI; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; PRASUGREL; TICAGRELOR; TICLOPIDINE; WARFARIN;

AGED; ARTICLE; ASSISTED CIRCULATION; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOGENIC SHOCK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HEART REINFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGICAL COMPLICATION; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; THROMBUS ASPIRATION; TRANSIENT ISCHEMIC ATTACK; UNITED KINGDOM; VALVULAR HEART DISEASE; ADVERSE EFFECTS; CASE CONTROL STUDY; CEREBRAL HEMORRHAGE; ENGLAND; EPIDEMIOLOGY; ISCHEMIC ATTACK, TRANSIENT; RECURRENT DISEASE; RETREATMENT; STROKE; WALES;

AGED; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; ENGLAND; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RECURRENCE; RETREATMENT; STROKE; WALES;

EID: 84937592171     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv113     Document Type: Article

References (31)

1. Singh M, Rihal CS, Gersh BJ, Lennon RJ, Prasad A, Sorajja P, Gullerud RE, Holmes DR Jr.Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention: A single-institution experience. Circulation 2007;115: 2835-2841.
2. Ratib K, Mamas MA, Routledge HC, Ludman PF, Fraser D, Nolan J. Influence of access site choice on incidence of neurologic complications after percutaneous coronary intervention. Am Heart J 2013;165:317-324.
3. Korn-Lubetzki I, Farkash R, Pachino RM, Almagor Y, Tzivoni D, Meerkin D. Incidence and risk factors of cerebrovascular events following cardiac catheterization. J Am Heart Assoc 2013;2:e000413.
4. Hoffman SJ, Holmes DR Jr, Rabinstein AA, Rihal CS, Gersh BJ, Lennon RJ, Bashir R, Gulati R. Trends, predictors, and outcomes of cerebrovascular events related to percutaneous coronary intervention: A 16-year single-center experience. JACC Cardiovasc Interv 2011;4:415-422.
5. Hoffman SJ, Routledge HC, Lennon RJ, Mustafa MZ, Rihal CS, Gersh BJ, Holmes DR Jr, Gulati R. Procedural factors associated with percutaneous coronary interventionrelated ischemic stroke. JACC Cardiovasc Interv 2012;5:200-206.
6. Aggarwal A, Dai D, Rumsfeld JS, Klein LW, Roe MT, American College of Cardiology National Cardiovascular Data R. Incidence and predictors of stroke associated with percutaneous coronary intervention. Am J Cardiol 2009;104:349-353.
7. Werner N, Bauer T, Hochadel M, Zahn R, Weidinger F, Marco J, Hamm C, Gitt AK, Zeymer U. Incidence and clinical impact of stroke complicating percutaneous coronary intervention: Results of the Euro heart survey percutaneous coronary interventions registry. Circ Cardiovasc Interv 2013;6:362-369.
8. Guptill JT, Mehta RH, Armstrong PW, Horton J, Laskowitz D, James S, Granger CB, Lopes RD. Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: Timing, characteristics, and clinical outcomes. Circ Cardiovasc Interv 2013;6:176-183.
9. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003;4:399-415.
10. Duffis EJ, Jones D, Tighe D, Moonis M. Neurological complications of coronary angiographic procedures. Expert Rev Cardiovasc Ther 2007;5:1113-1121.
11. Eggebrecht H, Oldenburg O, Dirsch O, Haude M, Baumgart D, Welge D, Herrmann J, Arnold G, Schmid KW, Erbel R. Potential embolization by atherosclerotic debris dislodged from aortic wall during cardiac catheterization: histological and clinical findings in 7, 621 patients. Catheter Cardiovasc Interv 2000;49:389-394.
12. Mack MJ, Head SJ, Holmes DR Jr, Stahle E, Feldman TE, Colombo A, Morice MC, Unger F, Erglis A, Stoler R, Dawkins KD, Serruys PW, Mohr FW, Kappetein AP. Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease. JACC Cardiovasc Interv 2013;6:344-354.
13. Genereux P, Bernard S, Palmerini T, Caixeta A, Rosner G, Reiss GR, Xu K, Mehran R, Stone GW. Incidence, predictors, and impact of neurological events in non-STsegment elevation acute coronary syndromes: The ACUITY trial. EuroIntervention 2014; doi:10.4244/EIJY14M07-06.
14. Dukkipati S, O'Neill WW, Harjai KJ, Sanders WP, Deo D, Boura JA, Bartholomew BA, YerkeyMW, Sadeghi HM, Kahn JK. Characteristics of cerebrovascular accidents after percutaneous coronary interventions. J Am Coll Cardiol 2004;43: 1161-1167.
15. Binsell-Gerdin E, Graipe A, Ogren J, Jernberg T, Mooe T. Hemorrhagic stroke the first 30 days after an acute myocardial infarction: incidence, time trends and predictors of risk. Int J Cardiol 2014;176:133-138.
16. Otto CM, Lind BK, KitzmanDW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341:142-147.
17. De Marco M, Gerdts E, Casalnuovo G, Migliore T, Wachtell K, Boman K, Dahlof B, Olsen MH, Kizer JR, Devereux RB, de Simone G. Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: The LIFE study. Am J Hypertens 2013;26:567-573.
18. Yip HK, Chang LT, Sun CK, Chen MC, Yang CH, Hung WC, Hsieh YK, Fang CY, Hang CL, Wu CJ, Chang HW. Platelet activity is a biomarker of cardiac necrosis and predictive of untoward clinical outcomes in patients with acute myocardial infarction undergoing primary coronary stenting. Circ J 2006;70:31-36.
19. Kirsch M, Vermes E, Boval B, Tual L, Mekontso-Dessap A, Drouet L, Loisance D. [Blood activation during long-term mechanical circulatory support]. Pathol Biol (Paris) 2005;53:97-104.
20. Mamas MA, Anderson SG, Ratib K, Routledge H, Neyses L, Fraser DG, Buchan I, de Belder MA, Ludman P, Nolan J, British Cardiovascular Intervention S, National Institute for Cardiovascular Outcomes R. Arterial access site utilization in cardiogenic shock in the United Kingdom: is radial access feasible? Am Heart J 2014;167: 900-908 e1.
21. Dangas GD, Claessen BE, Mehran R, Xu K, Fahy M, Parise H, Henriques JP, Ohman EM, White HD, Stone GW. Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes. JACC Cardiovasc Interv 2012;5:1097-1105.
22. Mehran R, Pocock S, Nikolsky E, Dangas GD, Clayton T, Claessen BE, Caixeta A, Feit F, Manoukian SV, White H, Bertrand M, Ohman EM, Parise H, Lansky AJ, Lincoff AM, Stone GW. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), andHORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. JACC Cardiovasc Interv 2011;4:654-664.
23. Ndrepepa G, Neumann FJ, Richardt G, Schulz S, Tolg R, Stoyanov KM, Gick M, Ibrahim T, Fiedler KA, Berger PB, Laugwitz KL, Kastrati A. Prognostic value of access and non-access sites bleeding after percutaneous coronary intervention. Circ Cardiovasc Interv 2013;6:354-361.
24. Spoon DB, Psaltis PJ, Singh M, Holmes DR Jr, Gersh BJ, Rihal CS, Lennon RJ, Moussa ID, Simari RD, Gulati R. Trends in cause of death after percutaneous coronary intervention. Circulation 2014;129:1286-1294.
25. Aggarwal B, Ellis SG, Lincoff AM, Kapadia SR, Cacchione J, Raymond RE, Cho L, Bajzer C, Nair R, Franco I, Simpfendorfer C, Tuzcu EM, Whitlow PL, Shishehbor MH. Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reporting. J Am Coll Cardiol 2013;62:409-415.
26. Kwok CS, Skinner J, Metcalf AK, Potter JF, Myint PK. Prior antiplatelet or anticoagulant therapy and mortality in stroke. Heart 2012;98:712-717.
27. Wolfe CD, Crichton SL, Heuschmann PU, McKevitt CJ, Toschke AM, Grieve AP, Rudd AG. Estimates of outcomes up to ten years after stroke: Analysis from the prospective South London Stroke Register. PLoS Med 2011;8:e1001033.
28. Bhalla A, Wang Y, Rudd A, Wolfe CD. Differences in outcome and predictors between ischemic and intracerebral hemorrhage: The South London Stroke Register. Stroke 2013;44:2174-2181.
29. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988.
30. Hippisley-Cox J, Coupland C, Brindle P. Derivation and validation of QStroke score for predicting risk of ischaemic strokein primary care and comparison with other risk scores: A prospective open cohort study. BMJ 2013;346:f2573.
31. SCAAR Annual Report 2011. Scand Cardiovasc J 2013;47(Suppl 62):55-76.